D. E. Shaw Research

D. E. Shaw Research (DESRES), based in New York City, develops and uses advanced computational technologies to understand the behavior of biologically and pharmaceutically significant molecules at an atomic level of detail, and to design precisely targeted, highly selective drugs for the treatment of various diseases. Among its core technologies is Anton, a proprietary special-purpose supercomputer that DESRES designed and constructed to vastly accelerate the process of molecular dynamics simulation. DESRES uses Anton machines and high-speed commodity hardware, together with machine learning methods and other computational techniques, in both internal and collaborative drug discovery programs. For more information, visit www.DEShawResearch.com...

Drug discovery,computational chemistry,machine learning,molecular dynamics simulation,biochemistry,scientific computing,drug discovery software tools,parallel computing,protein folding,force-field development,asic design,numerical analysis,and special-purpose computing architectures

D. e. shaw research operates in the Research services industry.

D. e. shaw research's revenue is 11m - 100m

D. e. shaw research has 51 - 200 employees.